These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1375249)

  • 21. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
    Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
    J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
    Raz R; Koren R; Bass D
    Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
    J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
    Milich DR; Louie RE; Chisari FV
    J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two distinct but overlapping antibody binding sites in the pre-S(2) region of HBsAg localized within 11 continuous residues.
    Milich DR; McLachlan A; Chisari FV; Nakamura T; Thornton GB
    J Immunol; 1986 Oct; 137(8):2703-10. PubMed ID: 2428872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches.
    Alves Vianna CO; da Silva E Mouta Júnior S; da Glória Teixeira Martins M; Batoreu NM; Queiroz JL; Gomes SA; Magalhães de Andrade Góes AC; Garcia Armoa GR; Marques CH; Baroni de Moraes MT
    J Immunol Methods; 2006 Jun; 313(1-2):38-47. PubMed ID: 16753174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-antigenicity relationship of peptides from the pre-S2 region of the hepatitis B virus surface antigen.
    Lee MK; Kim KL; Hahm KS; Yang KH
    Biochem Mol Biol Int; 1994 Aug; 34(1):159-68. PubMed ID: 7531533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S- and S-encoded viral surface antigens.
    Gerken G; Paterlini P; Manns M; Housset C; Terre S; Dienes HP; Hess G; Gerlich WH; Berthelot P; Meyer zum Büschenfelde KH
    Hepatology; 1991 Jan; 13(1):158-66. PubMed ID: 1988337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.
    Jung J; Iijima M; Yoshimoto N; Sasaki M; Niimi T; Tatematsu K; Jeong SY; Choi EK; Tanizawa K; Kuroda S
    Protein Expr Purif; 2011 Aug; 78(2):149-55. PubMed ID: 21515381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of two differently glycosylated molecular species of yeast-derived hepatitis B vaccine carrying the pre-S2 region.
    Kobayashi M; Asano T; Ohfune K; Kato K
    J Biotechnol; 1992 Nov; 26(2-3):155-62. PubMed ID: 1369148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region.
    Milich DR; McNamara MK; McLachlan A; Thornton GB; Chisari FV
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8168-72. PubMed ID: 2415982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-2 linked genetic control of immune responsiveness to hepatitis B surface antigen (HBsAg) in mice.
    Neurath AR; Stark D; Strick N; Sproul P
    J Med Virol; 1983; 12(4):227-36. PubMed ID: 6418854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity.
    Diminsky D; Schirmbeck R; Reimann J; Barenholz Y
    Vaccine; 1997; 15(6-7):637-47. PubMed ID: 9178464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the structural modifications accompanying the loss of HBsAg particle immunogenicity.
    Greiner VJ; Manin C; Larquet E; Ikhelef N; Gréco F; Naville S; Milhiet PE; Ronzon F; Klymchenko A; Mély Y
    Vaccine; 2014 Feb; 32(9):1049-54. PubMed ID: 24440114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B surface antigen induces an early-type hypersensitivity.
    Lei HY; Wang JY; Chang TT; Wang CC
    Clin Exp Immunol; 1991 Feb; 83(2):210-4. PubMed ID: 1993355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Possible roles of pre-S2 peptide in generation of chronic hepatitis B].
    Yamauchi K; Katoh T; Nishikawa M; Kimura T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):144-7. PubMed ID: 12442376
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification and characterization of pre-S-containing hepatitis B surface antigens produced in recombinant mammalian cell culture.
    Youn BW; Samanta H
    Vaccine; 1989 Feb; 7(1):60-8. PubMed ID: 2718608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.